DCC sells healthcare division for £1bn

07:02, 22nd April 2025
Vox News
Vox News
Company News
TwitterFacebookLinkedIn

    said it has agreed to sell its healthcare division to HealthCo Investment, an independently managed unit of funds managed or advised by Investindustrial Advisors for a total enterprise value of £1.05bn.
The Irish conglomerate on Monday said deal was a "material step" in its strategy to simplify operations and accelerate the growth of its energy business, which is the group's largest and highest returning division.

DCC added that it expected total expected net cash proceeds of £945m, including an unconditional deferred amount of £130m receivable within two years, and would return surplus funds to shareholders "while maintaining a strong, investment-grade balance sheet".

In the year to March 31, 2024, DCC Healthcare recorded revenue of £859.4m and adjusted operating profit of £88.1m. DCC Healthcare represented approximately 13% of the group's adjusted operating profit during the fiscal period.

"The disposal of DCC Healthcare is a material step in simplifying DCC's operations and focusing on our high growth, high return, energy business. Our strategy will continue to build DCC as a market-leading multi-energy business," said chief executive Donal Murphy.

"The profitable sale creates immediate value for our shareholders, and we are confident that Investindustrial will take DCC Healthcare forward in the best long‐term interests of its employees, customers and suppliers."

Reporting by Frank Prenesti for Sharecast.com

TwitterFacebookLinkedIn

Disclaimer & Declaration of Interest

The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Watchlist